(Q40388158)

20 September 2017

A tumor-specific conditionally replicative adenovirus vector expressing TRAIL for gene therapy of hepatocellular carcinoma (English)

1 reference

20 September 2017

0 references

1 reference

Ren XW

1

1 reference

20 September 2017

Liang M

2

1 reference

20 September 2017

Meng X

3

1 reference

20 September 2017

Ye X

4

1 reference

20 September 2017

Ma H

5

1 reference

20 September 2017

Zhao Y

6

1 reference

20 September 2017

Guo J

7

1 reference

20 September 2017

Cai N

8

1 reference

20 September 2017

Chen HZ

9

1 reference

20 September 2017

Ye SL

10

1 reference

20 September 2017

Hu F

11

1 reference

20 September 2017

1 February 2006

1 reference

20 September 2017

1 reference

20 September 2017

13

1 reference

20 September 2017

2

1 reference

20 September 2017

159-168

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700868

20 September 2017

0 references

cites work

Hepatocellular carcinoma: are we making progress?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Hepatocellular carcinoma: present status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

A position-dependent silencer plays a major role in repressing alpha-fetoprotein expression in human hepatoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Target gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Transcription initiation activity of adenovirus left-end sequence in adenovirus vectors with e1 deleted

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

The receptor for the cytotoxic ligand TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Apo2L/TRAIL and its death and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

A novel liver-specific zona pellucida domain containing protein that is expressed rarely in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Mad-overexpression down regulates the malignant growth and p53 mediated apoptosis in human hepatocellular carcinoma BEL-7404 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Improved production of adenovirus vectors expressing apoptotic transgenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

DNA replication of first-generation adenovirus vectors in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Adenovirus E1A oncogene expression in tumor cells enhances killing by TNF-related apoptosis-inducing ligand (TRAIL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Tumor necrosis factor-alpha induces Bax-Bak interaction and apoptosis, which is inhibited by adenovirus E1B 19K

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Regulation of the alpha-fetoprotein gene by the isoforms of ATBF1 transcription factor in human hepatoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Dependence of adenovirus infectivity on length of the fiber shaft domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

Insulation from viral transcriptional regulatory elements enables improvement to hepatoma-specific gene expression from adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

inferred from DOI database lookup

7 January 2021

based on heuristic

Transcriptional and Transforming Activities of the Adenovirus E1A Proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

inferred from DOI database lookup

7 January 2021

based on heuristic

Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700868

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700868

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference